Caption Management, LLC Amicus Therapeutics, Inc. Transaction History

Caption Management, LLC

$8.03 Billion
Q2 2025

A detailed history of Caption Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 50,000 shares of FOLD stock, worth $422,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,000

Previous 50,000 -0.0%

Holding current value

$422,000

Previous $408,000 29.9%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$5.64 - $8.0 $902,123 - $1.28 Million	-159,951 Reduced 94.28%	9,700 $55,000
Q1 2025 May 15, 2025	BUY	$8.16 - $9.85 $609,152 - $735,312	74,651 Added 78.58%	169,651 $1.38 Million
Q4 2024 Feb 14, 2025	BUY	$9.36 - $12.01 $889,200 - $1.14 Million	95,000 New	95,000 $894,000
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $197,975 - $257,325	21,900 New	21,900 $217,000
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $2.72 Million - $3.96 Million	272,500 Added 1009.26%	299,500 $4.25 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $274,320 - $322,757	23,287 Added 627.17%	27,000 $328,000
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $39,803 - $49,382	3,713 New	3,713 $46,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $327,988 - $425,850	33,400 New	33,400 $349,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $1.32 Million - $1.63 Million	-151,793 Reduced 76.03%	47,861 $461,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $496,423 - $917,296	36,854 Added 22.64%	199,654 $4.61 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $1.43 Million - $1.76 Million	110,974 Added 214.13%	162,800 $2.3 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $302,356 - $535,436	34,126 Added 192.8%	51,826 $783,000
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $117,351 - $197,532	17,700 New	17,700 $163,000
Q4 2019 Feb 13, 2020	SELL	$7.48 - $10.75 $112,200 - $161,250	-15,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $120,300 - $198,750	15,000 New	15,000 $119,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $131,300 - $170,900	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $137,600 - $171,200	10,000 New	10,000 $151,000

Others Institutions Holding FOLD

# of Institutions

304

Shares Held

332M

Call Options Held

396K

Put Options Held

249K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.37B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Amicus Therapeutics, Inc. Transaction History